For adults with anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD), learn how to prepare for treatment, what you may expect throughout, and tools and resources available to help you manage your disease.
Stay up-to-date with all recommended vaccinations during treatment with SOLIRIS. Tell your doctor about all the medicines and vaccines you receive.
Please see additional Important Safety Information for SOLIRIS, including Boxed WARNING regarding serious and life-threatening meningococcal infections, below.
Dr Sanders explains what happens before your first SOLIRIS infusion, why meningococcal vaccinations are important, and what you can expect during treatment.
SOLIRIS is a treatment that is given by intravenous (IV) infusion. Some people visit an infusion center to receive SOLIRIS while others prefer to have a visiting nurse administer their infusion at home. The location in which you receive your infusion can depend on your insurance and where you live. Contact a OneSource™ Team Member if you have questions.
Use our locator to find the infusion center closest to you.
Find an Infusion Center
When you enroll in OneSource, you’ll connect with a team of specialists trained in rare diseases. They can provide information and help with:
Planning ahead can help you manage your appointments as well as prepare activities that you can do while receiving your SOLIRIS treatment.
Be sure to arrive early for your appointment to fill out or sign any necessary paperwork. Once your infusion begins, it usually takes about 35 minutes to complete. Afterward, you will need to be monitored for at least 1 hour to ensure there are no infusion-related reactions.
SOLIRIS can cause serious side effects including serious infusion-related reactions. Tell your doctor or nurse right away if you get any of these symptoms during your SOLIRIS infusion: chest pain, trouble breathing or shortness of breath, swelling of your face, tongue, or throat, and feel faint or pass out. If you have an infusion-related reaction to SOLIRIS, your doctor may need to infuse SOLIRIS more slowly, or stop SOLIRIS.
Please see additional Important Safety Information for SOLIRIS, including Boxed WARNING regarding serious and life-threatening meningococcal infections, below.
Dosing occurs in 2 phases.
Treat where you’re comfortable. Many people go to an infusion center, but some can get their doses at home depending on insurance and location. Talk to your doctor about which option is right for you.
SOLIRIS was studied as an ongoing therapy. Your doctor will discuss the treatment timeline with you since it’s important to follow the prescribed schedule. If you miss a SOLIRIS infusion, call your doctor right away.
Dr Sanders explains what you can expect during an infusion and how resources like OneSource™ can help you manage treatment.
Building a community of people who know what you’re going through can be key for patients and caregivers. That’s why we’re developing events near you as well as online webinars you can join from home.
Sign up to get the latest news and information about anti-AQP4 antibody-positive NMOSD and how SOLIRIS may help.
*Required fields.
Your doctor will give you a Patient Safety Card about the risk of meningococcal infection. Carry it with you at all times during treatment and for 3 months after your last SOLIRIS dose. It is important to show this card to any doctor or nurse to help them diagnose and treat you quickly.
SOLIRIS may also increase the risk of other types of serious infections. Certain people may be at risk of serious infections with gonorrhea. Certain fungal infections (Aspergillus) may occur if you take SOLIRIS and have a weak immune system or a low white blood cell count.
Tell your doctor about all the vaccines you receive and medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements which could affect your treatment. It is important that you have all recommended vaccinations before you start SOLIRIS, receive 2 weeks of antibiotics if you immediately start SOLIRIS, and stay up-to-date with all recommended vaccinations during treatment with SOLIRIS.
Tell your doctor about any side effect that bothers you or that does not go away. These are not all the possible side effects of SOLIRIS. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch, or call 1-800-FDA-1088.
Please see the full Prescribing Information and Medication Guide for SOLIRIS, including Boxed WARNING regarding serious and life-threatening meningococcal infections.
Your doctor will give you a Patient Safety Card about the risk of meningococcal infection. Carry it with you at all times during treatment and for 3 months after your last SOLIRIS dose. It is important to show this card to any doctor or nurse to help them diagnose and treat you quickly.
SOLIRIS may also increase the risk of other types of serious infections. Certain people may be at risk of serious infections with gonorrhea. Certain fungal infections (Aspergillus) may occur if you take SOLIRIS and have a weak immune system or a low white blood cell count.
Tell your doctor about all the vaccines you receive and medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements which could affect your treatment. It is important that you have all recommended vaccinations before you start SOLIRIS, receive 2 weeks of antibiotics if you immediately start SOLIRIS, and stay up-to-date with all recommended vaccinations during treatment with SOLIRIS.
Tell your doctor about any side effect that bothers you or that does not go away. These are not all the possible side effects of SOLIRIS. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch, or call 1-800-FDA-1088.
Please see the full Prescribing Information and Medication Guide for SOLIRIS, including Boxed WARNING regarding serious and life-threatening meningococcal infections.